Merit Medical Systems Return on Tangible Equity 2010-2024 | MMSI
Current and historical return on tangible equity values for Merit Medical Systems (MMSI) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Merit Medical Systems Return On Tangible Equity Historical Data |
Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
2024-09-30 |
$0.12B |
$0.55B |
21.97% |
2024-06-30 |
$0.12B |
$0.60B |
22.04% |
2024-03-31 |
$0.10B |
$0.54B |
20.29% |
2023-12-31 |
$0.10B |
$0.49B |
18.84% |
2023-09-30 |
$0.10B |
$0.51B |
19.69% |
2023-06-30 |
$0.09B |
$0.47B |
18.07% |
2023-03-31 |
$0.08B |
$0.55B |
17.48% |
2022-12-31 |
$0.07B |
$0.51B |
16.78% |
2022-09-30 |
$0.06B |
$0.45B |
15.37% |
2022-06-30 |
$0.06B |
$0.42B |
15.87% |
2022-03-31 |
$0.05B |
$0.39B |
14.46% |
2021-12-31 |
$0.05B |
$0.36B |
16.01% |
2021-09-30 |
$0.04B |
$0.32B |
15.75% |
2021-06-30 |
$0.03B |
$0.29B |
11.56% |
2021-03-31 |
$0.00B |
$0.26B |
1.90% |
2020-12-31 |
$-0.01B |
$0.23B |
-5.38% |
2020-09-30 |
$-0.03B |
$0.20B |
-17.39% |
2020-06-30 |
$-0.03B |
$0.16B |
-19.08% |
2020-03-31 |
$-0.00B |
$0.16B |
-2.08% |
2019-12-31 |
$0.01B |
$0.15B |
4.16% |
2019-09-30 |
$0.02B |
$0.14B |
13.55% |
2019-06-30 |
$0.04B |
$0.13B |
19.31% |
2019-03-31 |
$0.04B |
$0.16B |
20.80% |
2018-12-31 |
$0.04B |
$0.14B |
20.79% |
2018-09-30 |
$0.04B |
$0.39B |
18.10% |
2018-06-30 |
$0.02B |
$0.15B |
10.81% |
2018-03-31 |
$0.02B |
$0.14B |
8.72% |
2017-12-31 |
$0.03B |
$0.21B |
12.46% |
2017-09-30 |
$0.03B |
$0.20B |
14.74% |
2017-06-30 |
$0.03B |
$0.23B |
20.53% |
2017-03-31 |
$0.03B |
$0.22B |
20.98% |
2016-12-31 |
$0.02B |
$0.10B |
15.04% |
2016-09-30 |
$0.02B |
$0.09B |
12.00% |
2016-06-30 |
$0.02B |
$0.18B |
13.04% |
2016-03-31 |
$0.02B |
$0.17B |
13.31% |
2015-12-31 |
$0.02B |
$0.17B |
14.22% |
2015-09-30 |
$0.03B |
$0.16B |
16.91% |
2015-06-30 |
$0.03B |
$0.16B |
19.93% |
2015-03-31 |
$0.03B |
$0.15B |
19.33% |
2014-12-31 |
$0.02B |
$0.14B |
19.39% |
2014-09-30 |
$0.02B |
$0.13B |
19.30% |
2014-06-30 |
$0.02B |
$0.12B |
17.98% |
2014-03-31 |
$0.02B |
$0.11B |
18.65% |
2013-12-31 |
$0.02B |
$0.10B |
17.43% |
2013-09-30 |
$0.01B |
$0.12B |
12.00% |
2013-06-30 |
$0.01B |
$0.10B |
9.92% |
2013-03-31 |
$0.02B |
$0.09B |
9.17% |
2012-12-31 |
$0.02B |
$0.09B |
10.19% |
2012-09-30 |
$0.02B |
$0.24B |
10.26% |
2012-06-30 |
$0.02B |
$0.23B |
9.51% |
2012-03-31 |
$0.02B |
$0.22B |
10.01% |
2011-12-31 |
$0.02B |
$0.24B |
11.61% |
2011-09-30 |
$0.02B |
$0.23B |
12.99% |
2011-06-30 |
$0.02B |
$0.23B |
10.81% |
2011-03-31 |
$0.02B |
$0.13B |
11.19% |
2010-12-31 |
$0.01B |
$0.12B |
9.14% |
2010-09-30 |
$0.01B |
$0.12B |
9.21% |
2010-06-30 |
$0.02B |
$0.17B |
13.62% |
2010-03-31 |
$0.02B |
$0.16B |
14.17% |
2009-12-31 |
$0.02B |
$0.16B |
14.94% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$5.972B |
$1.257B |
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
|